AAO: Association between GLP-1 receptor agonists and age-related macular degeneration explored
Crude odds ratios suggest an increased risk for age-related macular degeneration (AMD) in association with glucagon-like peptide-1 receptor agonist (GLP-1 RA) use, but this finding is reversed after adjustment for cardiometabolic confounding variables, according to a study presented at the annual meeting of the American Academy of Ophthalmology, held Oct. 9 to 12 in New Orleans.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
How trustworthy is AI breast cancer detection? New method gauges uncertainty for individual patients
United Kingdom
-
After stroke and AFib, restoring heart rhythm linked to lower risk of another stroke
United Kingdom
-
Newer anticoagulants may help prevent strokes in AFib patients with previous brain bleeds
United Kingdom
-
Air pollution and temperature variability are associated with higher blood glucose levels
United Kingdom
-
Personalized medicine breakthrough for childhood leukemia
United Kingdom
-
Celebrity Traitors: Neuroscientist on whether you can really make someone yawn by faking it
United Kingdom
-
STI rates drop following antibiotic use recommendations for gay and bisexual men
United Kingdom
-
Study finds health care provider photos in waiting rooms can strengthen patient trust
United Kingdom